MANDEEP BAJAJ to Fatty Liver
This is a "connection" page, showing publications MANDEEP BAJAJ has written about Fatty Liver.
Connection Strength
0.768
-
Potential of incretin-based therapies for non-alcoholic fatty liver disease. J Diabetes Complications. 2013 Jul-Aug; 27(4):401-6.
Score: 0.374
-
Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial. Diabetologia. 2011 Dec; 54(12):3093-100.
Score: 0.341
-
GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. JAMA Intern Med. 2024 Nov 01; 184(11):1314-1323.
Score: 0.053